… Fuzheng Kang'ai Formula (扶正抗癌方) in patients with advanced non-small cell lung cancer with epidermal growth factor receptor mutation: a randomized controlled …
X Yang, X Chai, W Wu, S Long, H Deng, Z Pan… - Chinese journal of …, 2018 - Springer
… disease, any evidence of severe or uncontrolled systemic disease (eg … for non-small cell
lung cancer with EGFR mutations. Clin … with extracorporeal high frequency thermotherapy plus …
lung cancer with EGFR mutations. Clin … with extracorporeal high frequency thermotherapy plus …
Mechanism of Fuzheng Kang'ai Formula (扶正抗癌方) Regulating Tumor Microenvironment in Non-Small Cell Lung Cancer
Y Tian, S Fu, B Li, L Yuan, Z Bing - Chinese journal of integrative medicine, 2022 - Springer
… Lung cancer remains the leading cause of cancer incidence and … (1) Lung squamous
cell carcinoma (LUSC) and lung … main pathological types of non-small cell lung cancer (NSCLC), …
cell carcinoma (LUSC) and lung … main pathological types of non-small cell lung cancer (NSCLC), …
吉非替尼对比培美曲塞联合顺铂治疗术后EGFR 突变阳性Ⅱ~ ⅢA 期肺腺癌的临床分析
谢厚耐， 李猛， 许林， 王晖， 彭岳… - 山东大学学报(医学 …, 2022 - yxbwk.njournal.sdu.edu.cn
… The incidence of sever adverse events(grade≥3)was … a significant DFS benefit in patients
with EGFR mutation-positive and … Non-small cell lung cancer, version 5.2017, NCCN clinical …
with EGFR mutation-positive and … Non-small cell lung cancer, version 5.2017, NCCN clinical …
[HTML][HTML] 新辅助化疗, 靶向治疗联合手术治疗临床Ⅲ 期EGFR 阳性肺腺癌
赵晨， 张辉， 刘冬， 张淼， 武文斌… - 中华胸部外科电子 …, 2021 - zhxbwkdzzz.cma-cmc.com.cn
… clinical stage Ⅲ lung adenocarcinoma with EGFR mutation[J]. … lymph node dissection and
incidence of serious complications … for IIIA-N2 non-small cell lung cancer based on epidermal …
incidence of serious complications … for IIIA-N2 non-small cell lung cancer based on epidermal …
非小细胞肺癌EGFR 突变状态与CT 特征的相关性
汪涛， 朱浩雨， 卜青松， 胡磊， 王文娟… - 中华肺部疾病杂志 …, 2023 - zhfbjbzz.cma-cmc.com.cn
… Correlation between EGFR mutation status and CT features in nonsmall cell lung cancer[J]. …
小细胞肺癌(non-small cell lung cancer, NSCLC)表皮生长因素受体(EGFR)突变状态的相关性. …
小细胞肺癌(non-small cell lung cancer, NSCLC)表皮生长因素受体(EGFR)突变状态的相关性. …
EGFR-TKI 单药或联合放疗治疗非小细胞肺癌肺毒性研究进展
聂志凤， 邢力刚 - 中国肿瘤临床, 2017 - cjco.cn
… cell lung cancer (NSCLC) patients with EGFR mutation. Pre-… by EGFR-TKIs monotherapy
features low incidence rate but … in advanced non-small cell lung cancer: a systematic review …
features low incidence rate but … in advanced non-small cell lung cancer: a systematic review …
老年非小细胞肺癌临床治疗现状及进展
邢嵘雪， 孙莉， 田应选 - 中华老年病研究电子杂志, 2021 - zhlnbyjdzzz.cma-cmc.com.cn
… Progress on clinical treatment of non-small cell lung cancer in elderly patients[J]. … Non-small
cell lung cancer (NSCLC) is the most common type of lung cancer, and elderly patients …
cell lung cancer (NSCLC) is the most common type of lung cancer, and elderly patients …
[HTML][HTML] SII/ALB 与EGFR 基因突变型晚期非小细胞肺癌预后的相关性分析
王梓聿， 李玲， 袁胜利 - Advances in Clinical Medicine, 2020 - hanspub.org
… systemic immune-inflammation index/albumin (SII/ALB) and the prognosis of patients with
advanced non-small cell lung cancer (… of EGFR-TKI in the treatment of EGFR mutant advanced …
advanced non-small cell lung cancer (… of EGFR-TKI in the treatment of EGFR mutant advanced …